Meeting
2017 ASCO Annual Meeting
Bim and soluble PD-L1 (sPD-L1) as predictive biomarkers of response to anti-PD-1 therapy in patients with melanoma and lung carcinoma.
Authors
Roxana Stefania Dronca
Mayo Clinic, Rochester, MN
Roxana Stefania Dronca , Aaron Scott Mansfield , Xin Liu , Susan Harrington , Elizabeth Ann Enninga , Lisa A. Kottschade , Chi Wan Koo , Robert R. McWilliams , Matthew Stephen Block , Wendy Kay Nevala , Svetomir Markovic , Haidong Dong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 35, 2017 (suppl; abstr 11534)
DOI
10.1200/JCO.2017.35.15_suppl.11534
Abstract #
11534
Poster Bd #
234
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
A novel method for identifying downstream signals in tumor-reactive T cells following PD-1 engagement and monitoring endogenous tumor immunity and immunotherapy.
First Author: Haidong Dong
Poster
2023 ASCO Annual Meeting
Evaluation of small extracellular vesicles as biomarkers of efficacy with anti-PD-1 mAb therapy in patients with recurrent/metastatic HNSCC.
First Author: Dan Paul Zandberg
Poster
2022 ASCO Gastrointestinal Cancers Symposium
The immune impact of PI3K-AKT pathway inhibition in colorectal cancer.
First Author: Maliha Nusrat
First Author: Cailin Joyce